Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:1151-1158
Published online before print September 4, 2006, doi: 10.1161/CIRCULATIONAHA.106.613646
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
114/11/1151    most recent
CIRCULATIONAHA.106.613646v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, C. S.
Right arrow Articles by Weiss, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, C. S.
Right arrow Articles by Weiss, R. G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Congestive
Right arrow Hypertrophy
Right arrow Energy metabolism

(Circulation. 2006;114:1151-1158.)
© 2006 American Heart Association, Inc.


Heart Failure

Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium

Craig S. Smith, MD; Paul A. Bottomley, PhD*; Steven P. Schulman, MD; Gary Gerstenblith, MD; Robert G. Weiss, MD*

From the Department of Medicine (C.S.S., S.P.S., G.G., R.G.W.), Cardiology Division, and Department of Radiology (P.A.B.), Division of Magnetic Resonance Research, The Johns Hopkins Hospital, Baltimore, Md.

Correspondence to Robert G. Weiss, MD, Carnegie 584, The Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287-6568. E-mail rweiss{at}jhmi.edu

Received January 12, 2006; revision received June 29, 2006; accepted July 6, 2006.

Background— The progression of pressure-overload left ventricular hypertrophy (LVH) to chronic heart failure (CHF) may involve a relative deficit in energy supply and/or delivery.

Methods and Results— We measured myocardial creatine kinase (CK) metabolite concentrations and adenosine triphosphate (ATP) synthesis through CK, the primary energy reserve of the heart, to test the hypothesis that ATP flux through CK is impaired in patients with LVH and CHF. Myocardial ATP levels were normal, but creatine phosphate levels were 35% lower in LVH patients (n=10) than in normal subjects (n=14, P<0.006). Left ventricular mass and CK metabolite levels in LVH were not different from those in patients with LVH and heart failure (LVH+CHF, n=10); however, the myocardial CK pseudo first-order rate constant was normal in LVH (0.36±0.04 s–1 in LVH versus 0.32±0.06 s–1 in normal subjects) but halved in LVH+CHF (0.17±0.06 s–1, P<0.001). The net ATP flux through CK was significantly reduced by 30% in LVH (2.2±0.7 µmol · g–1 · s–1, P=0.011) and by a dramatic 65% in LVH+CHF (1.1±0.4 µmol · g–1 · s–1, P<0.001) compared with normal subjects (3.1±0.8 µmol · g–1 · s–1).

Conclusions— These first observations in human LVH demonstrate that it is not the relative or absolute CK metabolite pool sizes but rather the kinetics of ATP turnover through CK that distinguish failing from nonfailing hypertrophic hearts. Moreover, the deficit in ATP kinetics is similar in systolic and nonsystolic heart failure and is not related to the severity of hypertrophy but to the presence of CHF. Because CK temporally buffers ATP, these observations support the hypothesis that a deficit in myofibrillar energy delivery contributes to CHF pathophysiology in human LVH.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Circ Cardiovasc ImagingHome page
T. H. Marwick and M. Schwaiger
The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 1: Tasks and Tools
Circ Cardiovasc Imaging, July 1, 2008; 1(1): 58 - 69.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Neglia, A. De Caterina, P. Marraccini, A. Natali, M. Ciardetti, C. Vecoli, A. Gastaldelli, D. Ciociaro, P. Pellegrini, R. Testa, et al.
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3270 - H3278.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Ashrafian, M. P. Frenneaux, and L. H. Opie
Metabolic Mechanisms in Heart Failure
Circulation, July 24, 2007; 116(4): 434 - 448.
[Abstract] [Full Text] [PDF]